Actively Recruiting

Age: 25Years - 50Years
FEMALE
NCT07193823

Sexual Dysfunction in Women With Multiple Sclerosis (MS)

Led by Ege University · Updated on 2025-09-26

140

Participants Needed

1

Research Sites

67 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Sexual dysfunction in women with multiple sclerosis (MS) is an important yet often overlooked problem. The primary objective of this study is to investigate the prevalence of sexual dysfunction in female patients diagnosed with MS. The secondary objective is to evaluate the relationship between sexual dysfunction and fatigue, depression, anxiety, overactive bladder symptoms, and cognitive dysfunction. For this purpose, the following validated instruments will be used: the Female Sexual Function Index (FSFI) to assess sexual dysfunction, the Brief International Cognitive Assessment for MS (BICAMS) to evaluate cognitive function, the Hospital Anxiety and Depression Scale (HADS) to assess depression and anxiety, the Fatigue Severity Scale (FSS) to measure fatigue, and the Overactive Bladder Questionnaire (OAB-V8) to evaluate overactive bladder symptoms.

CONDITIONS

Official Title

Sexual Dysfunction in Women With Multiple Sclerosis (MS)

Who Can Participate

Age: 25Years - 50Years
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Female patients aged 25-50 years
  • Literate and able to comprehend written and spoken instructions
  • Diagnosed with relapsing-remitting form of multiple sclerosis
  • Having a continuous/regular sexual partner
  • Expanded Disability Status Scale (EDSS) score 4 5
  • At least 3 months since the last relapse
  • Sexually active within the past 3 months
  • Spasticity level < grade 2 according to the Modified Ashworth Scale
Not Eligible

You will not qualify if you...

  • Pregnancy
  • Illiteracy or inability to understand spoken or written instructions
  • Absence of a continuous/regular sexual partner
  • Expanded Disability Status Scale (EDSS) score > 5
  • Not sexually active within the past 3 months
  • Spasticity level 6 grade 2 according to the Modified Ashworth Scale

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Ege University Faculty of Medicine, Department of Neurology

Izmir, Bornova, Turkey (Türkiye), 35100

Actively Recruiting

Loading map...

Research Team

M

Merve Dokumaci, Resident doctor

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here